In Brief: ChemTrak
This article was originally published in The Gray Sheet
ChemTrak: FDA requests more information regarding the firm's premarket approval application for the Aware home HIV test service. ChemTrak submitted the PMA in February 1995 ("The Gray Sheet" Feb. 20, 1995, In Brief). The company says it will respond to FDA's request "within the standard 180-day time frame set by the agency," noting that because of the "slower than previously anticipated development of the home HIV test market" it will focus more attention on "other opportunities which offer significantly greater short-term market potential"...
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.